AI Article Synopsis
- - Primary pure small cell neuroendocrine carcinoma of the bladder is a rare and aggressive cancer type, with an average five-year survival rate under 10%.
- - A case report details a 48-year-old male patient diagnosed with this rare cancer who underwent treatment involving TUR-T and adjuvant carboplatin-based chemotherapy along with radiotherapy.
- - Remarkably, after 30 months of treatment, the patient remains disease-free and has a normally functioning bladder.
Article Abstract
Primary pure small cell neuroendocrine carcinoma of the bladder is a rare condition. It is an aggressive tumor with an average five-year survival rate of less than 10% as cited by multiple case reports. We report a 48 year-old male patient with primary small cell neuroendocrine carcinoma of the bladder who was treated with TUR-T, adjuvant carboplatin-based chemotherapy and radiotherapy. The patient is free of disease at the end of 30 months with a normally functioning bladder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11255-005-3153-1 | DOI Listing |
Publication Analysis
Top Keywords
small cell
12
carcinoma bladder
12
cell neuroendocrine
8
neuroendocrine carcinoma
8
cell carcinoma
4
bladder
4
bladder case
4
case report
4
report review
4
review literature
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!